0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Olfactory identification ability among schizophrenia patients, their first-degree relatives and healthy subjects

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective:

          Olfactory impairments, including identification, have been reported in patients with schizophrenia, while few studies have examined the olfactory function of unaffected first-degree relatives of patients with schizophrenia, and the sample sizes of first-degree relatives were relatively small. Here, we investigated olfactory identification ability among patients with schizophrenia, first-degree relatives and healthy controls (HCs) using relatively large sample sizes at a single institute.

          Methods:

          To assess olfactory identification ability, the open essence odorant identification test was administered to 172 schizophrenia patients, 75 first-degree relatives and 158 healthy controls. Differences in olfactory identification and correlations between olfactory ability and clinical variables were examined among these participants.

          Results:

          We found a significant difference in olfactory identification ability among the diagnostic groups ( p = 7.65 × 10 −16). Schizophrenia patients displayed lower olfactory identification ability than first-degree relatives (Cohen’s d = −0.57, p = 3.13 × 10 −6) and healthy controls ( d = −1.00, p = 2.19 × 10 −16). Furthermore, first-degree relatives had lower olfactory identification ability than healthy controls ( d = −0.29, p = 0.039). Olfactory identification ability moderately and negatively correlated with the duration of illness ( r = −0.41, p = 1.88 × 10 −8) and negative symptoms ( r = −0.28, p = 1.99 × 10 −4) in schizophrenia patients, although the correlation with the duration of illness was affected by aging ( r = −0.24).

          Conclusions:

          Our results demonstrated that schizophrenia patients have impaired olfactory identification ability compared with first-degree relatives and healthy controls, and the impaired olfactory identification ability of first-degree relatives was intermediate between those in schizophrenia patients and healthy controls. Olfactory identification ability was relatively independent of clinical variables. Therefore, olfactory identification ability might be an intermediate phenotype for schizophrenia.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Olfactory disorders and quality of life--an updated review.

          Olfactory disorders are common and affect about one-fifth of the general population. The main causes of olfactory loss are post viral upper respiratory infection, nasal/sinus disease, and head trauma and are therefore very frequent among patients in ear, nose, and throat clinics. We have systematically reviewed the impact of quantitative, qualitative, and congenital olfactory disorders on daily life domains as well as on general quality of life and depression. From the extensive body of literature, it can be concluded that loss of the sense of smell leads to disturbances in important areas, mainly in food enjoyment, detecting harmful food and smoke, and to some extent in social situations and working life. Most patients seem to deal well and manage those restrictions. However, a smaller proportion has considerable problems and expresses a noticeable reduction in general quality of life and enhanced depression. The impact of coping strategies is discussed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction.

            The U.S. NHANES included chemosensory assessments in the 2011-2014 protocol. We provide an overview of this protocol and 2012 olfactory exam findings. Of the 1818 NHANES participants aged ≥40 years, 1281 (70.5 %) completed the exam; non-participation mostly was due to time constraints. Health technicians administered an 8-item, forced-choice, odor identification task scored as normosmic (6-8 odors identified correctly) versus olfactory dysfunction, including hyposmic (4-5 correct) and anosmic/severe hyposmic (0-3 correct). Interviewers recorded self-reported smell alterations (during past year, since age 25, phantosmia), histories of sinonasal problems, xerostomia, dental extractions, head or facial trauma, and chemosensory-related treatment and changes in quality of life. Olfactory dysfunction was found in 12.4 % (13.3 million adults; 55 % males/45 % females) including 3.2 % anosmic/severe hyposmic (3.4 million; 74 % males/26 % females). Selected age-specific prevalences were 4.2 % (40-49 years), 12.7 % (60-69 years), and 39.4 % (80+ years). Among adults ≥70 years, misidentification rates for warning odors were 20.3 % for smoke and 31.3 % for natural gas. The highest sensitivity (correctly identifying dysfunction) and specificity (correctly identifying normosmia) of self-reported olfactory alteration was among anosmics/severe hyposmics (54.4 % and 78.1 %, respectively). In age- and sex-adjusted logistic regression analysis, risk factors of olfactory dysfunction were racial/ethnic minority, income-to-poverty ratio ≤ 1.1, education
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

              Previous research has provided compelling support for olfactory dysfunction in schizophrenia patients, their first-degree relatives, and youth at-risk for psychosis. A previous meta-analysis revealed large effect sizes across olfactory tasks but was limited to 2 olfactory tasks and did not examine moderator variables. Thus, the current meta-analysis was undertaken to incorporate additional studies, risk cohorts, olfactory test domains, and moderator variable analyses.
                Bookmark

                Author and article information

                Contributors
                Journal
                Australian & New Zealand Journal of Psychiatry
                Aust N Z J Psychiatry
                SAGE Publications
                0004-8674
                1440-1614
                October 2023
                March 26 2023
                October 2023
                : 57
                : 10
                : 1367-1374
                Affiliations
                [1 ]School of Medicine, Gifu University, Gifu, Japan
                [2 ]Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan
                [3 ]Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan
                Article
                10.1177/00048674231164568
                936212cb-7d7c-4770-aa11-c6e7a974584b
                © 2023

                http://journals.sagepub.com/page/policies/text-and-data-mining-license

                History

                Comments

                Comment on this article